Axu00 0001 01
Axumin Injection, Solution
Product Images NDC 69932-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Axumin (NDC 69932-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Blue Earth Diagnostics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Axu00 0001 02
AXUMIN® is a non-pyrogenic, diagnostic injection used for intravenous use only. Each mL of the injection contains fluciclovine F 18, with a concentration range of 9 mCi/mL to 221 mCi/mL at End of Synthesis, sterile sodium citrate, hydrochloric acid, and sodium hydroxide. The injection must be used within 10 hours after the End of Synthesis and should be stored at controlled room temperature. The injection comes in a multiple-dose vial and should not be used if it appears cloudy or contains particulate matter. The recommended dose is based on the prescribing information and should be calculated from the date and time of calibration. AXUMIN® is manufactured by PETNET Solutions, Inc., Knoxville, TN 37932, for Blue Earth Diagnostics, Oxford OX4 4GA, UK. The radioactive material has a half-life of 109.7 min.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
